Long Term Outcomes of OCT Guided PCI in STEMI patients

Prior studies have shown the use of optical coherence tomography (OCT) have a significant influence on decision making, optimizing PCI and improving outcomes, vs conventional PCI. However, these studies have focused mainly on patients with stable angina or non-ST elevation MI. 

Resultados a largo plazo de la utilización de OCT para guiar ATC en pacientes con IAMCEST

The aim of this retrospective study was to find out whether the use of OCT can reduce mortality at long term (5 years) vs. PCI alone in patients with ST elevation MI (STEMI). 

Primary end point was all-cause mortality rate, and secondary end point was cardiovascular mortality rate.

3,897 were enrolled: 69.2% were treated with OCT and 30.8% with PCI alone. Mean patient age was approximately 60, and most patients were men. Among OCT patients, the most affected artery was the anterior descending, while in the PCI alone group, it was the right coronary. 

OCT guided patients were treated with stents less frequently during PCI (62.6% vs 80.2%; p<0.001). At 5 years, accumulated all-cause mortality and cardiovascular rates in the OCT guided cohort were 10.4% and 8.0%, respectively, significantly lower than the PCI alone cohort (19.0% and 14.1%; p<0.001).

Read also: Definite Pacemaker Implantation Predictors in TAVR High Implant Using Cusp Overlap.

Multivariable models showed the use of OCT might significantly reduce all-cause mortality at 5 years (HR: 0.689, CI 95%: 0.551-0.862) and cardiovascular mortality (HR: 0.692, IC 95%: 0.536-0.895). After propensity score matching for homogenous samples, the benefits of OCT guided PCI remained consistent in terms of all-cause (HR: 0.707, CI 95%: 0.548-0.913) and cardiovascular mortality (HR: 0.709, CI 95%: 0.526-0.955).

Conclusion

In this observational study, the use of OCT during PCI in patients with STEMI was associated to reduced mortality at long term vs. PCI alone. However, we need prospective randomized studies to confirm these results. 

Original Title: Five-year follow-up of OCT-guided percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction.

Reference: Luping He, MD et al EuroIntervention 2024;20:e937-e947.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

 

Dr. Andrés Rodríguez
Dr. Andrés Rodríguez
Member of the Editorial Board of solaci.org

More articles by this author

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

Evolution of Small Balloon-Expandable Valves

Small aortic rings (20 mm) have posed a significant challenge for both surgery and transcatheter aortic valve implantation (TAVI) due to their association with an...

TCT 2024 | FAVOR III EUROPA

The study FAVOR III EUROPA, a randomized trial, included 2,000 patients with chronic coronary syndrome, or stabilized acute coronary syndrome, and intermediate lesions. 1,008...

TCT 2024 – ECLIPSE: Randomized Study of Orbital Atherectomy vs Conventional PCI in Severely Calcified Lesions

Coronary calcification is associated with stent under-expansion and increased risk of both early and late adverse events. Atherectomy is an essential tool for uncrossable...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....